Omlyclo 150 mg (Omalizumab SOLUTION) 150 MG

OMLYCLO 150 MG is a subcutaneous solution containing omalizumab, used for managing allergic conditions. This medication helps reduce symptoms by targeting specific immune responses.

Strength

150 MG

Manufacturer / TM Owner

CELLTRION INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

OMLYCLO 150 MG is primarily used for the treatment of allergic conditions such as asthma and chronic idiopathic urticaria. It works by binding to immunoglobulin E (IgE), a key player in allergic reactions. This can help alleviate symptoms like wheezing, difficulty breathing, and persistent skin rashes. People often ask, 'What is OMLYCLO 150 MG used for?' It is typically prescribed for those who do not respond well to other treatments.

Side Effects

Common effects of OMLYCLO 150 MG may include reactions at the injection site, such as redness, swelling, or itching. Some users might experience headaches, nausea, or fatigue. These effects are generally mild and temporary. Severe allergic reactions are rare but possible and require immediate medical attention.

Precautions & Warnings

OMLYCLO 150 MG should be administered under medical supervision. It is important to inform your healthcare provider about any allergies or medical conditions before starting this treatment. The solution should be stored properly to maintain its effectiveness. Always follow the prescribed guidelines for administration and storage.

Avoid Interactions

OMLYCLO 150 MG may interact with other medications, including those that affect the immune system. It is advisable to discuss all current medications with your healthcare provider to avoid potential interactions. Alcohol and certain foods may also influence the effectiveness of this medication.

Frequently Asked Questions

OMLYCLO 150 MG is used to manage allergic conditions like asthma and chronic idiopathic urticaria by targeting immunoglobulin E (IgE).

OMLYCLO 150 MG is administered subcutaneously, typically under medical supervision.

Common side effects include reactions at the injection site, headaches, nausea, and fatigue.

It is important to discuss all current medications with your healthcare provider to avoid potential interactions.

OMLYCLO 150 MG should be stored according to the manufacturer's guidelines to maintain its effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.